Program (November 2023)
The program features over 1,300 rapid-fire presentations offered in more than 100 sessions throughout the five-day event. Click on the day below to review the sessions, then click on the session number to see a listing of presentations and speakers within a session.

  View/Search/Print Complete 2023 Program Brochure in PDF
View/Print Entire November 2023 Program
TUESDAY PROGRAMS
Program A:(SESSIONS 1-8) – 6:45 A.M. – 6:02 P.M. (10 CME CREDIT HOURS)
PROGRESS IN THE TREATMENT OF DISEASES OF THE CORONARY ARTERIES, HEART VALVES, AND THE THORACIC AND ABDOMINAL AORTA
Location:GRAND BALLROOM EAST, 3RD FLOOR
 
Program B:(SESSIONS 9-16) – 6:47 A.M. – 5:59 P.M. (9.75 CME CREDIT HOURS)
PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN AND HYBRID VASCULAR SURGERY, AND TREATMENT OF AORTIC COARCTATION
Location:GRAND BALLROOM WEST, 3RD FLOOR
 
Program C-1:(SESSIONS 17-18) – 7:00 A.M. – 12:00 P.M. (4.5 CME CREDIT HOURS)
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH
Location:TRIANON BALLROOM, 3RD FLOOR
 
Program C-2:(SESSIONS 19-22) – 1:00 P.M. – 6:06 P.M. (5 CME CREDIT HOURS)
INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
Location:TRIANON BALLROOM, 3RD FLOOR
 
WEDNESDAY PROGRAMS
Program D:(SESSIONS 23-30) – 6:40 A.M. – 6:20 P.M. (9.75 CME CREDIT HOURS)
PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
Location:GRAND BALLROOM EAST, 3RD FLOOR
 
Program E:(SESSIONS 31-38) – 6:40 A.M. – 6:30 P.M. (10.25 CME CREDIT HOURS)
NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI-ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE
Location:GRAND BALLROOM WEST, 3RD FLOOR
 
Program F:(SESSIONS 39-46) – 6:50 A.M. – 6:30 P.M. (10.75 CME CREDIT HOURS)
MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC AND CAROTID TOPICS
Location:TRIANON BALLROOM, 3RD FLOOR
 
THURSDAY PROGRAMS
Program G:(SESSIONS 47-54) – 6:50 A.M. – 5:58 P.M. (10 CME CREDIT HOURS)
EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY
Location:GRAND BALLROOM EAST, 3RD FLOOR
 
Program H:(SESSIONS 55-63) – 7:00 A.M. – 5:52 P.M. (9.75 CME CREDIT HOURS)
NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS
Location:GRAND BALLROOM WEST, 3RD FLOOR
 
Program I:(SESSIONS 64 - 73) – 7:00 A.M. – 6:40 P.M. (11.25 CME CREDIT HOURS)
SUPERFICIAL VENOUS DISEASE
Location:TRIANON BALLROOM, 3RD FLOOR
 
Program J:(SESSIONS 74 - 78) – 8:00 A.M. - 12:30 P.M. (4.5 CME CREDIT HOURS)
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT
Location:MURRAY HILL SUITES, 2ND FLOOR
 
FRIDAY PROGRAMS
Program K:(SESSIONS 79-86) – 6:40 A.M. – 5:56 P.M. (10.25 CME CREDIT HOURS)
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), STRING SIGN, CAROTID CLOT, SIGNIFICANCE OF MRI LESIONS, CAROTID CONTROVERSIES AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE
Location:GRAND BALLROOM EAST, 3RD FLOOR
 
Program L:(SESSIONS 87-94) – 6:52 A.M. – 5:40 P.M. (9.75 CME CREDIT HOURS)
NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; AUGMENTED REALITY AND ARTIFICIAL INTELLIGENCE; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA
Location:GRAND BALLROOM WEST, 3RD FLOOR
 
Program M:(SESSIONS 95-104) – 7:00 A.M. – 5:57 P.M. (10.5 CME CREDIT HOURS)
DEEP VENOUS DISEASE
Location:TRIANON BALLROOM, 3RD FLOOR
 
SATURDAY PROGRAMS
Program N:(SESSIONS 105-108) – 7:00 A.M. – 12:35 P.M. (5.5 CME CREDIT HOURS)
TOPICS TOO IMPORTANT TO MISS IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE
Location:GRAND BALLROOM EAST, 3RD FLOOR
 
Program O:(SESSIONS 109-113) – 8:00 A.M. – 4:00 P.M. (6.75 CME CREDIT HOURS)
IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS
Location:GRAND BALLROOM WEST, 3RD FLOOR
 
Program P:(SESSIONS 114-123) – 7:00 A.M. – 5:30 P.M. (9.5 CME CREDIT HOURS)
ADVANCES IN VASCULAR IMAGING AND DIAGNOSIS
Location:MURRAY HILL SUITES, 2ND FLOOR
 
COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS A, B AND C ARE CONCURRENT TUESDAY PROGRAMS
PROGRAM A (SESSIONS 1-8 - PROGRESS IN THE TREATMENT OF DISEASES OF THE CORONARY ARTERIES, HEART VALVES, AND THE THORACIC AND ABDOMINAL AORTA; 6:45 A.M. to 6:02 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 1: PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
SESSION 2: PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING
SESSION 6: MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON THE UK NICE AAA GUIDELINES AND OTHER AORTIC PATHOLOGY
SESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
SESSION 8: MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
PROGRAM B (SESSIONS 9-16 - PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN AND HYBRID VASCULAR SURGERY, AND TREATMENT OF AORTIC COARCTATION 6:47 A.M. to 5:59 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 9: PROGRESS IN VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
SESSION 11: MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
SESSION 12: PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
SESSION 13: NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI) (See also Session 87)
SESSION 14: PART 1: VASCULAR SURGERY’S NUMBERS AND IDENTITY AND HOW TO MEET THE SPECIALTY’S NEEDS FOR ITS SERVICES; THE IMPORTANCE OF MENTORSHIP IN VASCULAR SURGERY
PART 2: LATE BREAKING DEVELOPMENTS IN COVID RELATED VASCULAR DISEASE ISSUES

SESSION 15: PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
SESSION 16: UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
PROGRAM C-1 (SESSIONS 17-18 - MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH; 7:00 A.M. to 12:00 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 1
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 2
PROGRAM C-2 (SESSIONS 19-22 - INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS; 1:00 P.M. to 6:06 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 19: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
SESSION 20: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
SESSION 21: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE
SESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI)

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS D, E AND F ARE CONCURRENT WEDNESDAY PROGRAMS
PROGRAM D (SESSIONS 23-30 - PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT 6:40 A.M. to 6:20 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs)
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
SESSION 28: NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
PROGRAM E (SESSIONS 31-38 - NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI- ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE; 6:40 A.M. to 6:30 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
SESSION 32: CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
SESSION 34: TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
SESSION 36: ISSUES IMPORTANT IN VASCULAR SURGERY: PRACTICE PATTERNS, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTs: THE FDA: STATISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS
PROGRAM F (SESSIONS 39-46 - MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC AND CAROTID TOPICS; 6:50 A.M. to 6:30 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), INFLAMMATORY ANEURYSMS AND THEIR TREATMENT
SESSION 40: MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
SESSION 42: PROGRESS IN TREATING ILIAC LESIONS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
SESSION 44: MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
SESSION 45: HOT AORTIC TOPICS
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS; ANTI-ATHEROSCLEROSIS VACCINE

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS G, H AND I AND J ARE CONCURRENT THURSDAY PROGRAMS
PROGRAM G (SESSIONS 47-54 - EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY; 6:50 A.M. to 5:58 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS, TRIBUTE TO ROGER M. GREENHALGH
SESSION 48: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 50: A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
SESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
SESSION 52: MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
SESSION 53: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
SESSION 54: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
PROGRAM H (SESSIONS 55-63 - NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS; 7:00 A.M. to 5:52 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 55: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR; ENDOGRAFTS FOR TREATMENT OF CONNECTIVE TISSUE DISORDERS
SESSION 57: NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
SESSION 58: NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS
SESSION 59: NEW OR UPDATED INFORMATION ON RE-ENTRY DEVICES, LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28), PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
SESSION 62: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
SESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
PROGRAM I (SESSIONS 64-73 - SUPERFICIAL VENOUS DISEASE; 7:00 A.M. to 6:40 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 64: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
SESSION 65: VENOUS GUIDELINES, IMPORTANT PAPERS AND REIMBURSEMENT
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES 1
SESSION 67: SUPERFICIAL VEIN TREATMENT STRATEGIES II
SESSION 68: SUPERFICIAL VEIN TREATMENT STRATEGIES III
SESSION 69: SUPERFICIAL VEIN TREAMENT STRATEGIES IV
SESSION 70: SUPERFICIAL VEIN TREAMENT STRATEGIES V
SESSION 71: AESTHETIC PHLEBOLOGY AND SCLEROTHERAPY STRATEGIES
SESSION 72: SUPERFICIAL VEIN TREATMENT STRATEGIES VI
SESSION 73: LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA, AND ULCERS
PROGRAM J (SESSIONS 74-78 - MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT; 8:00 A.M. to 12:30 P.M.)
Location: Murray Hill Suites, 2nd Floor

SESSION 74: EMERGING TRENDS IN ISCHEMIC STROKE TREATMENT
SESSION 75: ACCESS ISSUES (PROXIMAL AND DISTAL): PEARLS
SESSION 76: ACUTE STROKE THROMBECTOMY MASTERS SESSION
SESSION 77: CAROTID AND CEREBRAL ANEURYSMS LATEST TRENDS
SESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDS

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS K, L AND M ARE CONCURRENT FRIDAY PROGRAMS
PROGRAM K (SESSIONS 79-86 - PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), STRING SIGN, CAROTID CLOT, SIGNIFICANCE OF MRI LESIONS, CAROTID CONTROVERSIES AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE; 6:40 A.M. to 5:56 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
SESSION 81: MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
SESSION 83: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
SESSION 84: MORE HOT CAROTID TOPICS: TREATMENT IN 2023 OF PATCH INFECTIONS, STRING SIGN, CAROTID DISSECTIONS AND WEBS; MANAGEMENT OF ARTERIAL INJURIES DURING CENTRAL VENOUS CATHETERIZATION; OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS; VALUE OF LOCAL ANESTHESIA; STROKE RISK WITH ACS PLAQUES - A WAY TO PREDICT HIGH RISK PLAQUES
SESSION 85: NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS AND MORE HOT AND CONTROVERSIAL CAROTID TOPICS
SESSION 86: NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE
PROGRAM L (SESSIONS 87-94 - NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; AUGMENTED REALITY AND ARTIFICIAL INTELLIGENCE; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA; 6:52 A.M. to 5:40 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 87: POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE LOWER EXTREMITY OCCLUSIVE LESION TREATMENT WITH DCBs AND ATHERECTOMY
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
SESSION 89: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
SESSION 90: AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE OUTCOMES, IMAGING AND DEVICE GUIDANCE DURING VASCULAR PROCEDURES
SESSION 91: TWO PRESENTATIONS AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
SESSION 92: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
SESSION 93: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
SESSION 94: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
COMBINED VEITHsymposium and AVIDsymposium SESSIONS
VEITHsymposium PROGRAM M (SESSIONS 95-104 - DEEP VENOUS DISEASE; 7:00 A.M. to 5:57 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 95: DEEP VENOUS WORK-UP, VENOUS STENT CHARACTERISTICS
SESSION 96: VENOUS STENT TRIALS
SESSION 97: FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
SESSION 98: VENOUS THROMBOSIS SCIENCE AND TREATMENT STRATEGIES
SESSION 99: THROMBUS REMOVAL THROMBECTOMY DEVICES AND OTHER ISSUES TO CONSIDER
SESSION 100: VENOUS REFLUX ISSUES
SESSION 101: PELVIC VEIN DISORDERS
SESSION 102: MORE VENOUS THROMBOSIS, IVC
SESSION 103: DEEP VEIN VALVE TECHNOLOGIES, MORE STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION
SESSION 104: VENOUS ANEURYSMS, MORE IMPORTANT DEEP VENOUS CONCEPTS

6:00 AM - General Registration - New York Hilton Midtown
                 Gramercy Suite East, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Grand Ballroom Foyer - 3rd Floor

PROGRAMS N, O AND P ARE CONCURRENT SATURDAY PROGRAMS
PROGRAM N (SESSIONS 105-108 - TOPICS TOO IMPORTANT TO MISS IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE; 7:00 A.M. to 12:40 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 105: LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
SESSION 106: MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
SESSION 107: AORTIC TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS) AND SPINE EXPOSURE (6- MINUTE TALKS)
SESSION 108: AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
PROGRAM O (SESSIONS 109-113 - IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS; 8:00 A.M. to 4:00 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 109: IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 110: MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 111: POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 112: NOVEL TECHNOLOGIES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 113: UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
COMBINED VEITHsymposium and AVIDsymposium SESSIONS
VEITHsymposium PROGRAM P (SESSIONS 114-123 - ADVANCES IN VASCULAR IMAGING AND DIAGNOSIS; 7:00 A.M. to 5:30 P.M.)
Location: Murray Hill Suites, 2nd Floor

SESSION 114: VASCULAR SONOGRAPHY IN ACUTE AND CHRONIC LIMB ISCHEMIA
SESSION 115: WAVEFORMS – LESSONS LEARNED FROM CASES WITH UNIQUE WAVEFORMS WHICH LEAD TO FURTHER TESTING OR UNUSUAL PATHOLOGY
SESSION 116: LESSONS LEARNED IN THE VASCULAR LAB THROUGH THE QA ACCREDITATION PROCESS
SESSION 117: BEYOND THE CORE CONCEPTS IN VASCULAR TESTING: ARE YOU MEETING THE STANDARD
SESSION 118: TECHNICAL SKILLS LAB
SESSION 119: INTERPRETING WITH THE MASTERS
SESSION 120: VENOUS IMAGING: TESTING FOR LEG REFLUX AND PELVIC VEIN DISORDERS
SESSION 121: ERGONOMICS - AUDIT YOUR VASCULAR LAB: ARE YOU ERGONOMICALLY “SOUND”; ERGONOMICS “SOS” (SOUND OCCUPATIONAL STRATEGIES)
SESSION 122: PRACTICE ENHANCEMENTS AND PHILOSOPHICAL ISSUES
SESSION 123: ABDOMEN; CURVEBALLS AND CONTROVERSIES
2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
2008 | 2007 | 2006 | 2005